What MDS Misdiagnoses Trends Tells Us About Blood Cancer Diagnostics
Blood disorders known as MDS are difficult to diagnose putting patients at increased risk for treatment mistakes from misdiagnosis.
Read More
Search Results for: lung cancer
Predicting Early Cancers with Molecular Vibrations in Serum
A team of scientists developed a label-free SERS-Artificial intelligence method for cancer screening (SERS-AICS).
Read More
Novel ML Blood Test Detects Cancers with Genome-Wide Mutations in cfDNA Molecules
New blood testing tech combines genome-wide sequencing of single molecules of DNA shed from tumors and machine learning.
Read More
General Biologicals Debuts Circulating Tumor Cell Cancer Detection Products
GBC’s two CTC detection systems are used for early detection, treatment validation, and therapy monitoring with rapid diagnostic solutions.
Read More
AlloSure Lung dd-cfDNA Testing Service Receives Medicare Coverage
CareDx, Inc. has announced that its AlloSure Lung donor-derived cell-free DNA molecular testing service has received Medicare coverage.
Read More